In an effort to illustrate that genomic surveillance can build the foundation for scaleable precision phage therapy, an international collaboration analyzed the genomes of over 15,000 cases of ...
A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration seeking the approval of ...
Training supports multi-site clinical trial of MDMA-assisted Massed Prolonged Exposure Therapy for PTSD in active-duty service members. First-of-its-kind therapist preparation supports the Department ...
Numinus is a leading player in the emerging field of psychedelic therapy. This article delves into their groundbreaking work and collaboration with MAPS (Multidisciplinary Association for Psychedelic ...
Do you feel haunted by past experiences? Are anxiety, depression, or intrusive thoughts constantly disrupting your peace? Do you struggle with strained relationships, feeling disconnected and ...
If approved for medical use, the Drug Enforcement Administration would be required to reschedule the drug. MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine ...
SAN JOSE, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the completion of a therapy training initiative supporting clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback